Aclarion, Inc.
NASDAQ: ACONW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Brent Ness
- Employees
- 5
- Headquarters
- Broomfield, United States
- IPO year
- 2022
- Market cap
- $13.2K
- Website
- https://www.aclarion.com
Loading ACONW…
Loading profile data…Frequently asked questions about ACONW
What does Aclarion, Inc. (ACONW) do?
Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify...
Where does ACONW trade?
Aclarion, Inc. (ACONW) trades on the NASDAQ Capital Market.
What sector is ACONW in?
Aclarion, Inc. (ACONW) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Aclarion, Inc.?
Brent Ness is the chief executive officer of Aclarion, Inc. (ACONW).
Where is Aclarion, Inc. headquartered?
Aclarion, Inc. is headquartered in United States.
Does ACONW pay a dividend?
Aclarion, Inc. (ACONW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACONW go public?
Aclarion, Inc. (ACONW) completed its initial public offering in 2022.